Gordon Dunn

CIK: 0001958139

Transaction Breakdown

Open Market Buys (P)6 (85.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

QNRX

Quoin Pharmaceuticals, Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

QNRX
Quoin Pharmaceuticals, Ltd.
Dec 23, 2024
Purchase(P)
Direct
122.2K shares at avg. $0.45$55K
QNRX
Quoin Pharmaceuticals, Ltd.
Dec 9, 2024
Award(A)
Share Option (Right to Buy)
Direct
339K shares-
QNRX
Quoin Pharmaceuticals, Ltd.
Sep 10, 2024
Purchase(P)
Direct
10K shares at avg. $0.91$9K
QNRX
Quoin Pharmaceuticals, Ltd.
Sep 10, 2024
Purchase(P)
Direct
10K shares at avg. $0.71$7K
QNRX
Quoin Pharmaceuticals, Ltd.
Sep 9, 2024
Purchase(P)
Direct
4K shares at avg. $0.78$3K
QNRX
Quoin Pharmaceuticals, Ltd.
Sep 9, 2024
Purchase(P)
Direct
4K shares at avg. $0.80$3K
QNRX
Quoin Pharmaceuticals, Ltd.
Sep 9, 2024
Purchase(P)
Direct
856 shares at avg. $0.80$684.8

		Type	Shares	Price		Ownership
Dec 23, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	122,221	$0.45	$54,999	Direct
Dec 9, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Award(A) Share Option (Right to Buy)	338,994	-	-	Direct
Sep 10, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	10,000	$0.91	$9,100	Direct
Sep 10, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	10,000	$0.71	$7,100	Direct
Sep 9, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	4,000	$0.78	$3,120	Direct
Sep 9, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	4,000	$0.80	$3,200	Direct
Sep 9, 2024	QNRX Quoin Pharmaceuticals, Ltd.	Purchase(P)	856	$0.80	$685	Direct

1-7 of 7 transactions

About Dunn Gordon

Dunn Gordon (SEC CIK 0001958139) files insider reports with the SEC as Chief Financial Officer of Quoin Pharmaceuticals, Ltd. (QNRX).

Signal8 holds 3 ownership filings by Dunn Gordon, all Form 4s, filed between Sep 11, 2024 and Dec 27, 2024. Those filings report 7 transactions, from Sep 9, 2024 to Dec 23, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Dunn Gordon's filings is in ASHBURN, VA.

Recent filings by Dunn Gordon

Dec 23, 2024: Open-market purchase of QNRX shares (Form 4, code P).
Dec 9, 2024: Grant or award of QNRX derivative securities (Form 4, code A).
Sep 10, 2024: Open-market purchases of QNRX shares (2 lines, Form 4, code P).
Sep 9, 2024: Open-market purchases of QNRX shares (3 lines, Form 4, code P).

Other insiders filing for Quoin Pharmaceuticals, Ltd. (QNRX)

LANGER DENNIS, Director
Carter Denise P., Chief Operating Officer
Myers Michael, Chief Executive Officer
Lawlor Sally Bridget, Chief Financial Officer
Culverwell Anthony James, Director
Cooper Joseph Patrick, Director

How to read Form 4 transaction codes